FDA Inspection 1170339 — Reliance Life Sciences Private Limited
The FDA completed an inspection of Reliance Life Sciences Private Limited on Apr 15, 2022 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE